Nektar Therapeutics · NASDAQ:NKTR
The Vanguard Group reported a 5.04% stake in Nektar Therapeutics (Schedule 13G)
Event Dec 31, 2025 · Filed Jan 30, 2026
The Vanguard Group reported a 5.04% stake in Nektar Therapeutics, 1,027,089 shares, as a passive investor on Dec 31, 2025. Filed Jan 30, 2026 (Schedule 13G).
- Stake
- 5.04%
- Shares
- 1,027,089
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| The Vanguard Group | 5.04% | 1,027,089 |
Source
Related
- Nektar Therapeutics
- The Vanguard Group
- Nektar Therapeutics shareholders
- Schedule 13G/A · The Vanguard Group · Mar 27, 2026
- Schedule 13G/A · The Vanguard Group · Oct 31, 2025
- Schedule 13G/A · Two Seas Capital LP · Sep 28, 2026
- Form 4 · Whitfield Roy A · Sep 25, 2026
- Form 4 · Greer R Scott · Sep 25, 2026
- Form 4 · Chess Robert · Sep 25, 2026
- Form 4 · Brainard Diana · Sep 25, 2026